title: Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate.
abstract: Glomerular epithelial protein 1 (GLEPP1) is a receptor tyrosine phosphatase present on the apical cell surface of the glomerular podocyte. The GLEPP1 gene (PTPRO:) was disrupted at an exon coding for the NH(2)-terminal region by gene targeting in embryonic stem cells. Heterozygote mating produced the expected genotypic ratio of 1:2:1, indicating that the Ptpro(-/-) genotype does not lead to embryonic or neonatal lethality. Kidney and glomerular structure was normal at the gross and light microscopic levels. Scanning and transmission electron microscopy showed that Ptpro(-/-) mice had an amoeboid rather than the typical octopoid structure seen in the wild-type mouse podocyte and that there were blunting and widening of the minor (foot) processes in association with altered distribution of the podocyte intermediate cytoskeletal protein vimentin. Reduced filtration surface area in association with these structural changes was confirmed by finding reduced glomerular nephrin content and reduced glomerular filtration rate in Ptpro(-/-) mice. There was no detectable increase in the urine albumin excretion of Ptpro(-/-) mice. After removal of one or more kidneys, Ptpro(-/-) mice had higher blood pressure than did their wild-type littermates. These data support the conclusion that the GLEPP1 (Ptpro) receptor plays a role in regulating the glomerular pressure/filtration rate relationship through an effect on podocyte structure and function.
authors.affiliation: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
authors.forename: B L
authors.initials: BL
authors.lastname: Wharram
authors.forename: M
authors.initials: M
authors.lastname: Goyal
authors.forename: P J
authors.initials: PJ
authors.lastname: Gillespie
authors.forename: J E
authors.initials: JE
authors.lastname: Wiggins
authors.forename: D B
authors.initials: DB
authors.lastname: Kershaw
authors.forename: L B
authors.initials: LB
authors.lastname: Holzman
authors.forename: R C
authors.initials: RC
authors.lastname: Dysko
authors.forename: T L
authors.initials: TL
authors.lastname: Saunders
authors.forename: L C
authors.initials: LC
authors.lastname: Samuelson
authors.forename: R C
authors.initials: RC
authors.lastname: Wiggins
mesh_terms: D000418:Albumins / Q000378:metabolism; D000818:Animals; D004847:Epithelial Cells / Q000648:ultrastructure; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D020022:Genetic Predisposition to Disease; D005838:Genotype; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D007678:Kidney Glomerulus / Q000166:cytology / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010641:Phenotype; D017027:Protein Tyrosine Phosphatases / Q000235:genetics / Q000502:physiology*; D011506:Proteins / Q000378:metabolism; D051381:Rats; D054631:Receptor-Like Protein Tyrosine Phosphatases, Class 3; D011995:Recombination, Genetic; D012795:Sialoglycoproteins / Q000378:metabolism; D014746:Vimentin / Q000378:metabolism
chemical_list: D000418:Albumins; D008565:Membrane Proteins; D011506:Proteins; D012795:Sialoglycoproteins; D014746:Vimentin; C113267:nephrin; C001643:podocalyxin; C516888:PTPRO protein, human; D017027:Protein Tyrosine Phosphatases; C516890:Ptpro protein, mouse; C516891:Ptpro protein, rat; D054631:Receptor-Like Protein Tyrosine Phosphatases, Class 3